ARCT PEER ANALYSIS

Arcturus Therapeutics Holdings Inc — metric-by-metric comparison with peers and the industry median

ARCTArcturus Therapeutics Holdings Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ARCTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ARCT	RTALB	MSB	TLX	Ind. Median
P/E	—	4.78	—	—	18.06
P/B	1.13	0.59●	—	6.38	3.62
EV/EBITDA	—	72.98●	—	120.20	15.13
P/S	4.76	6.52	31.30	3.24●	10.65

Financial Health
Metric	ARCT	RTALB	MSB	TLX	Ind. Median
Current Ratio	6.31●	1.21	—	1.43	5.90
Debt/Equity	12.5%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	2.78	0.90●	—	13.13	1.15

Profitability
Metric	ARCT	RTALB	MSB	TLX	Ind. Median
Net Margin	-173.5%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-37.0%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-27.3%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-148.9%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	ARCT	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-66.4%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	ARCT	IPSC	OVID	CHRS	NAUT	PLX	Ind. Median
P/E	—	—	—	—	—	12.78	18.06
P/B	1.13	0.76●	1.03	2.90	1.48	2.92	3.62
EV/EBITDA	—	—	—	—	—	6.84	15.13
P/S	4.76	—	28.57	4.86	—	2.57●	10.65

Financial Health
Metric	ARCT	IPSC	OVID	CHRS	NAUT	PLX	Ind. Median
Current Ratio	6.31	10.25	10.17	1.56	11.85●	3.15	5.90
Debt/Equity	12.5%	18.1%	0.7%●	69.2%	20.0%	12.6%	10.9%
NetDebt/EBITDA	2.78	0.97	6.42	0.70	1.32	-1.94●	1.15

Profitability
Metric	ARCT	IPSC	OVID	CHRS	NAUT	PLX	Ind. Median
Net Margin	-173.5%	—	-339.3%	-323.5%	—	20.1%●	-125.7%
ROE	-37.0%	-42.7%	-18.8%	—	-33.7%	27.3%●	-47.5%
ROA	-27.3%	-33.6%	-15.7%	-47.6%	-28.2%	17.4%●	-35.8%
EBITDA Margin	-148.9%	—	-337.0%	-341.0%	—	29.2%●	-105.8%

Growth + Dividend
Metric	ARCT	IPSC	OVID	CHRS	NAUT	PLX	Ind. Median
Rev. Growth	-66.4%	-100.0%	1,199.6%●	-76.3%	-100.0%	27.8%	5.1%
NI Growth	—	—	—	—	—	292.3%	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ARCT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.